Shares of Medtronic (MDT) are off 14 cents at $40.50 after the medical device maker this morning reported fiscal Q4 revenue in line with consensus at $4.196 billion, versus $4.192 billion expected, and profit per share two cents ahead of expectations at 90 cents per share.
The forecast for this year, was also better than expected, at $3.50 to $3.60, versus the consensus $3.52.
It was the first quarter with over $4 billion in revenue in company history, management said.
International revenue, 41% of the total, rose 20% in Q4, or 11% on a constant-currency basis.
No comments:
Post a Comment